Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

2020 Gastroenterology 1,547 citations

Abstract

Abstract BACKGROUD & AIMS: Although SARS-CoV-2 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. We investigated changes in fecal microbiomes of patients with SARS-CoV-2 infection during hospitalization and associations with severity and fecal shedding of virus. METHODS We performed shotgun metagenomic sequencing analyses of fecal samples from 15 patients with COVID-19 in Hong Kong, from February 5 through March 17, 2020. Fecal samples were collected 2 or 3 times per week from time of hospitalization until discharge; disease was categorized as mild (no radiographic evidence of pneumonia), moderate (pneumonia was present), severe (respiratory rate ≥30/min, or oxygen saturation ≤93% when breathing ambient air), or critical (respiratory failure requiring mechanical ventilation, shock, or organ failure requiring intensive care). We compared microbiome data with those from 6 subjects with community-acquired pneumonia and 15 healthy individuals (controls). We assessed gut microbiome profiles in association with disease severity and changes in fecal shedding of SARS-CoV-2. RESULTS Patients with COVID-19 had significant alterations in fecal microbiomes compared with controls, characterized by enrichment of opportunistic pathogens and depletion of beneficial commensals, at time of hospitalization and at all timepoints during hospitalization. Depleted symbionts and gut dysbiosis persisted even after clearance of SARS-CoV-2 (determined from throat swabs) and resolution of respiratory symptoms. The baseline abundance of Coprobacillus, Clostridium ramosum, and Clostridium hathewayi correlated with COVID-19 severity; there was an inverse correlation between abundance of Faecalibacterium prausnitzii (an anti-inflammatory bacterium) and disease severity. Over the course of hospitalization, Bacteroides dorei, Bacteroides thetaiotaomicron, Bacteroides massiliensis, and Bacteroides ovatus, which downregulate expression of ACE2 in murine gut, correlated inversely with SARS-CoV-2 load in fecal samples from patients. CONCLUSIONS In a pilot study of 15 patients with COVID-19, we found persistent alterations in the fecal microbiome during the time of hospitalization, compared with controls. Fecal microbiota alterations were associated with fecal levels of SARS-CoV-2 and COVID-19 severity. Strategies to alter the intestinal microbiota might reduce disease severity.

Keywords

Coronavirus disease 2019 (COVID-19)Gut flora2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyInternal medicineImmunologyOutbreakDiseaseInfectious disease (medical specialty)

MeSH Terms

AdultAgedBetacoronavirusCOVID-19Coronavirus InfectionsDysbiosisFecesFemaleGastrointestinal MicrobiomeGastrointestinal TractHong KongHospitalizationHumansMaleMiddle AgedPandemicsPilot ProjectsPneumoniaViralSARS-CoV-2

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
159
Issue
3
Pages
944-955.e8
Citations
1547
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1547
OpenAlex
73
Influential
1269
CrossRef

Cite This

Tao Zuo, Fen Zhang, Grace Lui et al. (2020). Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology , 159 (3) , 944-955.e8. https://doi.org/10.1053/j.gastro.2020.05.048

Identifiers

DOI
10.1053/j.gastro.2020.05.048
PMID
32442562
PMCID
PMC7237927

Data Quality

Data completeness: 90%